MHRA Explains Entry Criteria for UK's New Innovative Medicines Pathway
‘Innovation Passport’ Will Be Gateway To Targeted Development
A new licensing route is to be introduced by the UK MHRA next year for products that meet specific criteria, such as treating life threatening conditions or rare diseases and where there is a significant patient need. At a webinar this week, an MHRA medical assessor looked at the requirements that products will have to meet to enter the new pathway.
